Eli Lilly and Nektar Develop Autoimmune Therapy

31.07.2017 - US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...